Edge Medical Ventures (EdgeMed) has launched a new $70M medtech fund, which has already started to invest following an initial close.

Edge Medical Ventures（EdgeMed）推出了一个新的7000万美元的medtech基金，该基金在首次关闭后已经开始投资。

Edge Medical Ventures intends to make several investments per year of $1M-$3M per company and will also reserve around $5M-$6M for follow-on investments in each company.

Edge Medical Ventures计划每年对每家公司进行几笔100万至300万美元的投资，并将为每家公司的后续投资预留约500万至600万美元。

The founding partners of the new fund are veterans of the medical device industry, having led the MEDX Xelerator incubator for the last seven years. They include: Shai Policker, CEO, Gal Atarot, CTO and Noam Taichler, CFO.  MEDX Xelerator is a leading Israeli Innovation Authority incubator which invested in and created 16 medical device companies..

。他们包括：首席执行官Shai Policker、首席技术官Gal Atarot和首席财务官Noam Taichler。MEDX Xelerator是以色列领先的创新机构孵化器，投资并创建了16家医疗器械公司。。

Edge's anchor investors include a major medical device corporation, Consensus Business Group ('CBG'), a leading investment group with a portfolio that includes pharma, biotech, med-tech, cleantech, real estate and more, a family office based in the UK, and other partners.

Edge的主要投资者包括一家大型医疗器械公司Consensus Business Group（“CBG”），这是一家领先的投资集团，其投资组合包括制药、生物技术、医疗技术、清洁技术、房地产等，以及一家总部位于英国的家族理财办公室和其他合作伙伴。

Shai Policker said, 'During the past seven plus years at MEDX Xelerator, we came to appreciate the amazing talent and novel ideas emerging from the Israeli medtech echo system. We also noticed the scarcity of capital. We believe this combination has created a unique opportunity. Our goal is to continue the proven venture creation collaboration with strategic partners as well as with leading hospitals worldwide, and to invest in those high-impact cutting-edge technology companies that have already undergone de-risking through pre-clinical and clinical research.'.

Shai Policker说：“在MEDX Xelerator过去的七年多时间里，我们开始欣赏以色列医疗技术回声系统涌现出的惊人人才和新颖想法。我们还注意到资本的稀缺性。我们相信这种组合创造了一个独特的机会。我们的目标是继续与战略合作伙伴以及全球领先的医院进行经验证的创业合作，并投资于那些已经通过临床前和临床研究降低风险的高影响力尖端技术公司。”。

Vincent Tchenguiz, Founder and Chairman of CBG Investment Group said, 'I am glad to partner with the MEDX Xelerator team once again and invest in their new medtech fund. I believe and know that Israeli health technologies hold a great opportunity and the ability to change reality in the near-term and especially in the future.

CBG投资集团创始人兼董事长文森特·琴奎兹（VincentTchenguiz）表示，“我很高兴再次与MEDX Xelerator团队合作，投资他们的新医疗技术基金。我相信并知道，以色列卫生技术在短期内，特别是在未来，拥有改变现实的巨大机会和能力。

Through the new Edge Medical Venture fund, we will be able to create an impact and promote medical companies to their next level of success.'.

通过new Edge Medical Venture fund，我们将能够产生影响，推动医疗公司取得更大的成功。”。

Areas of interest include breakthrough medical device technologies in vascular interventions, urology, gastrointestinal, women's health, home treatment, imaging and minimal invasive surgery.  The fund's first investment has already been made and will be disclosed separately soon.

感兴趣的领域包括血管介入、泌尿外科、胃肠道、女性健康、家庭治疗、成像和微创手术等领域的突破性医疗设备技术。该基金的第一笔投资已经完成，不久将另行披露。

About Edge Medical Ventures (EdgeMed)

关于Edge Medical Ventures（EdgeMed）

Edge Medical Ventures is a fund investing in innovative medical technologies with headquarters in Jersey City, New Jersey and Or Yehuda, Israel. The fund also has offices in Detroit, Michigan.

Edge Medical Ventures是一家投资创新医疗技术的基金，总部位于新泽西州泽西市和以色列耶胡达。该基金还在密歇根州底特律设有办事处。

Edge operates a venture studio that identifies and develops groundbreaking medical devices and solutions in close collaboration with strategic partners, healthcare professionals, researchers, and industry experts around the world to accelerate the development and commercialization of novel technologies..

Edge运营着一家风险工作室，与全球战略合作伙伴、医疗保健专业人员、研究人员和行业专家密切合作，识别和开发开创性的医疗设备和解决方案，以加速新技术的开发和商业化。。

For more information, please visit www.edgemed.vc

有关更多信息，请访问www.edgemed.vc

Media Contact:

媒体联系人：

Marjie Hadad

马尔杰·哈达德

General Manager

总经理

Must Have Communications

必须有通信

[email protected]

[受电子邮件保护]

1-917-790-1178 or +972-54-536-5220

1-917-790-1178或+972-54-536-5220

Source: prnewswire.com

来源：prnewswire.com